Associations between biomarker levels and clinical features vary by group; in IPAF, KL-6 and SP-D correlate inversely with baseline PFTs and exercise capacity, while in CTD-ILD, they correlate with BAL cellularity and disease duration. This evidence concerns the gene SFTPD and interstitial lung disease.